03.01.07
The U.S. Patent and Trademark Office (USPTO) has completed a formal review of Sabinsa Corp.’s (Piscataway, NJ) Patent No. 5,972,382, “Use of piperine as a bioavailability enhancer” and concluded that all points outlined within the patent are valid. Four examiners with the USPTO reviewed the patent, which is one of five granted that surrounds Sabinsa’s branded ingredient Bioperine, a standardized piperine composition derived from black pepper extract that has been shown in clinical research to increase the absorption of nutrients in nutritional supplement formulations.